HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Pascal Thomas Roger Giudicelli Pierre Fuentes Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doddoli, C. Articles by Fuentes, P. Search for Related Content PubMed PubMed Citation Articles by Doddoli, C. Articles by Fuentes, P. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2001;20:339-343
© 2001 Elsevier Science NL

Is lung cancer surgery justified in patients with direct mediastinal invasion?

Department of Thoracic Surgery, Sainte-Marguerite Hospital, Marseille, France

Received 9 October 2000; received in revised form 31 March 2001; accepted 6 April 2001.

Corresponding author. Tel.: +33-491-744741; fax: +33-491-744590
e-mail: cdoddoli{at}mail.ap-hm.fr

Objective: To assess the results of the surgical treatment of patients with stage IIIB non-small cell lung carcinoma (NSCLC) invading the mediastinum (T4). Methods: Twenty-nine patients were operated on from 1986 to 1999. Histology was squamous cell carcinoma in 17 patients, adenocarcinoma in eight, large cell carcinoma in two and neuroendocrinal carcinoma in two. Three patients received a preoperative chemotherapy (n=2) or radiochemotherapy (n=1). The lung resection consisted of a pneumonectomy in 25 patients and a lobectomy in four. The procedure was extended to one of the following structures: superior vena cava (SVC) (n=17), aorta (n=1), left atrium (n=5) and carina (n=6). Seventeen patients had a postoperative regimen including radiochemotherapy (n=12), radiotherapy (n=4), or chemotherapy (n=1). Results: Complete R0 resection was achieved in 25 patients, whereas four patients had a microscopically (n=1) or macroscopically (n=3) residual disease. The operative mortality rate was 7% (n=2). Non-fatal major complications occurred in eight patients (28%). Overall 5-year survival rate was 28% (median 11 months), including the operative mortality. The median survival of the 18 patients with an N0 or N1 disease was 16 months whereas the median survival of the 11 patients with an N2 disease was 9 months. At completion of the study, 22 patients have died, two postoperatively and 10 from pulmonary causes without evidence of cancer. Conclusions: Surgical management of T4 NSC lung cancer invading the mediastinum should be considered, in the absence of N2 disease, when a complete resection is achievable.

Key Words: Lung cancer • Extended resection • Postoperative mortality • Survival

This article has been cited by other articles:

				F. Farjah, D. E. Wood, T. K. Varghese Jr, R. G. Symons, and D. R. Flum Trends in the operative management and outcomes of T4 lung cancer. Ann. Thorac. Surg., August 1, 2008; 86(2): 368 - 374. [Abstract] [Full Text] [PDF]

				A. Borri, F. Leo, G. Veronesi, P. Solli, D. Galetta, R. Gasparri, F. Petrella, P. Scanagatta, D. Radice, and L. Spaggiari Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1266 - 1272. [Abstract] [Full Text] [PDF]

				Y. Sekine, K. Yasufuku, S. Motohashi, and T. Fujisawa Triple reconstruction of pulmonary artery, superior vena cava and bronchus for lung cancer Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 509 - 510. [Abstract] [Full Text] [PDF]

				M. Ohta, H. Hirabayasi, H. Shiono, M. Minami, H. Maeda, H. Takano, S. Miyoshi, and H. Matsuda Surgical resection for lung cancer with infiltration of the thoracic aorta J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 804 - 808. [Abstract] [Full Text] [PDF]

				L. Spaggiari, M. D' Aiuto, G. Veronesi, G. Pelosi, T. de Pas, G. Catalano, and F. de Braud Extended Pneumonectomy With Partial Resection of the Left Atrium, Without Cardiopulmonary Bypass, for Lung Cancer Ann. Thorac. Surg., January 1, 2005; 79(1): 234 - 240. [Abstract] [Full Text] [PDF]

				G. B. Ratto, R. Costa, G. Vassallo, A. Alloisio, P. Maineri, and P. Bruzzi Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer Ann. Thorac. Surg., July 1, 2004; 78(1): 234 - 237. [Abstract] [Full Text] [PDF]

				C. Doddoli, F. Barlesi, B. Chetaille, L. Garbe, P. Thomas, R. Giudicelli, and P. Fuentes Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery Ann. Thorac. Surg., April 1, 2004; 77(4): 1168 - 1172. [Abstract] [Full Text] [PDF]

				S. Hasegawa, T. Bando, N. Isowa, Y. Otake, K. Yanagihara, F. Tanaka, K. Inui, and H. Wada The use of cardiopulmonary bypass during extended resection of non-small cell lung cancer Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 676 - 679. [Abstract] [Full Text] [PDF]

				C. C.M. Pitz, A. B. de la Riviere, H. A. van Swieten, C. J.J. Westermann, J.-W. J. Lammers, and J. M.M. van den Bosch Results of surgical treatment of T4 non-small cell lung cancer Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 1013 - 1018. [Abstract] [Full Text] [PDF]

				E. Cetinkaya, A. Turna, P. Yildiz, R. Dodurgali, M. A. Bedirhan, A. Gurses, and V. Yilmaz Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 1000 - 1005. [Abstract] [Full Text] [PDF]